Group I Metabotropic Glutamate Receptors Modulate Motility and Enteric Neural Activity in the Mouse Colon

Biomolecules. 2023 Jan 9;13(1):139. doi: 10.3390/biom13010139.

Abstract

Glutamate is the major excitatory neurotransmitter in the central nervous system, and there is evidence that Group-I metabotropic glutamate receptors (mGlu1 and mGlu5) have established roles in excitatory neurotransmission and synaptic plasticity. While glutamate is abundantly present in the gut, it plays a smaller role in neurotransmission in the enteric nervous system. In this study, we examined the roles of Group-I mGlu receptors in gastrointestinal function. We investigated the expression of Grm1 (mGlu1) and Grm5 (mGlu5) in the mouse myenteric plexus using RNAscope in situ hybridization. Live calcium imaging and motility analysis were performed on ex vivo preparations of the mouse colon. mGlu5 was found to play a role in excitatory enteric neurotransmission, as electrically-evoked calcium transients were sensitive to the mGlu5 antagonist MPEP. However, inhibition of mGlu5 activity did not affect colonic motor complexes (CMCs). Instead, inhibition of mGlu1 using BAY 36-7620 reduced CMC frequency but did not affect enteric neurotransmission. These data highlight complex roles for Group-I mGlu receptors in myenteric neuron activity and colonic function.

Keywords: calcium imaging; colonic motor complexes; enteric glia; enteric nervous system; gastrointestinal tract; metabotropic glutamate receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium* / pharmacology
  • Central Nervous System* / metabolism
  • Glutamic Acid / metabolism
  • Mice
  • Neurons / metabolism
  • Synaptic Transmission

Substances

  • Calcium
  • Glutamic Acid

Grants and funding

This study was funded by the NHMRC Australia (GNT 1158952 to J.C.B.). The mGlu5-KO mice were generated using funding from an NHMRC Project Grant to A.J.H. and T.R. (GNT 112688). A.J.L.L. is funded by a Research Training Program scholarship. A.J.H. was supported by an NHMRC Principal Research Fellowship (GNT 1117148). T.R. is a NHMRC Boosting Dementia Research Leadership Fellow (APP1136529); L.A.S. was supported by an ARC DECRA fellowship (DE180100261). M.M.H. is an ARC DECRA fellow (DE190101209).